ALPS Advisors’s NRC Health Common Stock NRC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.02M Buy
47,073
+10,311
+28% +$191K ﹤0.01% 697
2026
Q1
$624K Sell
36,762
-3,830
-9% -$65.1K ﹤0.01% 665
2025
Q4
$762K Hold
40,592
﹤0.01% 640
2025
Q3
$519K Hold
40,592
﹤0.01% 656
2025
Q2
$682K Sell
40,592
-1,532
-4% -$20.7K ﹤0.01% 585
2025
Q1
$539K Sell
42,124
-1,532
-4% -$24.6K ﹤0.01% 581
2024
Q4
$770K Buy
43,656
+1,532
+4% +$29.1K ﹤0.01% 540
2024
Q3
$963K Buy
+42,124
New +$952K 0.01% 497

Other funds holding NRC

ALPS Advisors's NRC Position: Q2 2026 in Review

ALPS Advisors increased its NRC Health Common Stock (NRC) stake by 28% in Q2 2026, buying an estimated $191K and bringing the position to 47,073 shares worth $1.02M. The position accounts for ﹤0.01% of the portfolio, ranked #697.

ALPS Advisors first reported a position in NRC in Q3 2024 and has held it in 8 quarters since. 124 funds tracked by Wall St. Rank hold NRC as of Q2 2026.

  • ALPS Advisors held 47,073 shares of NRC Health Common Stock worth $1.02M as of Q2 2026.
  • ALPS Advisors bought 10,311 NRC Health Common Stock shares in Q2 2026, an estimated $191K.
  • NRC Health Common Stock made up ﹤0.01% of ALPS Advisors's portfolio in Q2 2026, its #697 holding.
  • ALPS Advisors first reported a position in NRC Health Common Stock in Q3 2024 and has held it in 8 quarters since.
  • 124 funds tracked by Wall St. Rank held NRC Health Common Stock as of Q2 2026.

Based on ALPS Advisors's 13F filing for Q2 2026, filed 29 Jul 2026.